Urtica dioica pollen

Identification

Summary

Urtica dioica pollen is an extract from Urtica dioica pollen used in allergy testing.

Generic Name

Urtica dioica pollen

DrugBank Accession Number

DB10763

Background

Urtica dioica pollen is the pollen of the Urtica dioica plant. Urtica dioica pollen is mainly used in allergenic testing.

Type

Biotech

Groups

Approved

Biologic Classification

Allergenics
Allergen Extract

Synonyms

• nettle pollen extract

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	Region	Image
Nettle	Solution	0.05 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
Nettle	Injection, solution	40000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Nettle	Injection, solution	0.05 g/1mL	Percutaneous	ALK-Abello, Inc.	1965-01-01	Not applicable
Nettle	Solution	0.001 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
Nettle	Solution	0.025 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
ANKAFERD DERİ ÇÖZELTİSİ İÇEREN AMPUL	Urtica dioica pollen (6 g/100mL) + Alpinia officinarum leaf (7 g/100mL) + Glycyrrhiza glabra (7 g/100mL) + Grape seed oil (8 g/100mL) + Thyme (5 g/100mL)	Solution	Topical	İMMÜN GIDA İLAÇ KOZMETİK SAN. VE TİC. LTD. ŞTİ.	2017-11-07	Not applicable
PROSTAGOOD PLUS KAPSÜL, 120 ADET	Urtica dioica pollen (120 mg) + Saw palmetto (160 mg)	Capsule	Oral	ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.	2006-03-22	Not applicable
PROSTAGOOD PLUS KAPSÜL, 60 ADET	Urtica dioica pollen (120 mg) + Saw palmetto (160 mg)	Capsule	Oral	ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.	2006-03-22	Not applicable
Treamtent Set TS347738	Urtica dioica pollen (0.002 g/1mL) + Alternaria alternata (0.002 g/1mL) + Amaranthus retroflexus pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (4000 [AU]/1mL) + Carya illinoinensis pollen (0.001 g/1mL) + Carya tomentosa pollen (0.001 g/1mL) + Cochliobolus sativus (0.00008 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Felis catus hair (400 [BAU]/1mL) + Fraxinus americana pollen (0.002 g/1mL) + Juglans nigra pollen (0.002 g/1mL) + Morus rubra pollen (0.002 g/1mL) + Pascopyrum smithii pollen (0.002 g/1mL) + Phleum pratense pollen (160 [BAU]/1mL) + Platanus occidentalis pollen (0.002 g/1mL) + Populus alba pollen (0.001 g/1mL) + Populus deltoides pollen (0.002 g/1mL) + Populus nigra pollen (0.001 g/1mL) + Quercus alba pollen (0.002 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1986-10-31	Not applicable
Treatment Set TS129085	Urtica dioica pollen (0.002 g/1mL) + Acer rubrum pollen (0.0004 g/1mL) + Alternaria alternata (0.0004 g/1mL) + Amaranthus retroflexus pollen (0.0004 g/1mL) + Ambrosia artemisiifolia pollen (800 [AU]/1mL) + Carya tomentosa pollen (0.002 g/1mL) + Cladosporium cladosporioides (0.002 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Dermatophagoides farinae (120 [AU]/1mL) + Dermatophagoides pteronyssinus (120 [AU]/1mL) + Morus rubra pollen (0.002 g/1mL) + Mucor racemosus (0.002 g/1mL) + Plantago lanceolata pollen (0.0004 g/1mL) + Platanus occidentalis pollen (0.0004 g/1mL) + Pleospora herbarum (0.002 g/1mL) + Poa pratensis pollen (32 [BAU]/1mL) + Quercus alba pollen (0.0004 g/1mL) + Rumex acetosella pollen (0.0004 g/1mL) + Salsola kali pollen (0.0004 g/1mL) + Sorghum halepense pollen (0.00008 g/1mL) + Ulmus americana pollen (0.0004 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1986-10-31	Not applicable

Categories

Drug Categories

• Cell-mediated Immunity
• Increased Histamine Release
• Increased IgG Production
• Non-Standardized Pollen Allergenic Extract

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

DNB59M1NVU

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347910892

RxNav

852046

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Solution	Topical
Injection, solution	Intradermal; Subcutaneous	0.05 g/1mL
Injection, solution	Intradermal; Subcutaneous	0.1 g/1mL
Injection, solution	Intradermal; Subcutaneous	10000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	20000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	40000 [PNU]/1mL
Injection, solution	Percutaneous	0.05 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.001 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.025 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.05 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	20000 [PNU]/1mL
Injection	Cutaneous; Intradermal; Subcutaneous	0.05 g/1mL
Injection, solution	Percutaneous; Subcutaneous	1 g/20mL
Injection, solution	Percutaneous; Subcutaneous	0.05 g/1mL
Injection, solution	Percutaneous; Subcutaneous	0.1 g/1mL
Capsule	Oral
Injection, solution	Intradermal; Subcutaneous

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53